APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radioactive Source

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

Selected research

Market Outlook & Growth Opportunities

Global Radioactive Source Market Outlook and Growth Opportunities 2026

1 January 2026197 pages

Choose your research edition.

Industry ResearchRadioactive Source Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioactive Source Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Radioactive Source Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioactive Source Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioactive Source Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

NRG and Mayak maintained absolute dominance in the global radioactive source manufacturers ranking in 2019, together accounted for about 35% of the market share.

This report provides an overview of the global Radioactive Source market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Radioactive Source and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radioactive Source revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Radioactive Source market.

Radioactive Source Segment by Company

NRG

Mayak

NTP Radioisotopes

ANSTO

Nordion

IRE

Curium Pharma

Eckert & Ziegler Strahlen

China Isotope & Radiation Corporation (CIRC)

Polatom

Board of Radiation and Isotope Technology

Radioactive Source Segment by Type

Mo-99

Co-60

Na-22

Co-57

Sr-90

I-131

Ir-192

Se-75

Kr-85

Am-241

Radioactive Source Segment by Application

Medical

Industrial

Agriculture

Scientific Research

Others

Radioactive Source Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radioactive Source status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Radioactive Source key companies, revenue, market share, and recent developments.

3. To split the Radioactive Source breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Radioactive Source market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radioactive Source significant trends, drivers, influence factors in global and regions.

6. To analyze Radioactive Source competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioactive Source market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioactive Source and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioactive Source.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radioactive Source industry.

Chapter 3: Detailed analysis of Radioactive Source company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Radioactive Source in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Radioactive Source in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radioactive Source Industry Trends Table 2. Radioactive Source Industry Drivers Table 3. Radioactive Source Industry Opportunities and Challenges Table 4. Radioactive Source Industry Restraints Table 5. Global Radioactive Source Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radioactive Source Revenue Share by Company (2021-2026) Table 7. Global Radioactive Source Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Radioactive Source Key Company Manufacturing Base & Headquarters Table 9. Global Radioactive Source Company, Product Type & Application Table 10. Global Radioactive Source Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Radioactive Source by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mo-99 Table 15. Significant Companies of Co-60 Table 16. Significant Companies of Na-22 Table 17. Significant Companies of Co-57 Table 18. Significant Companies of Sr-90 Table 19. Significant Companies of I-131 Table 20. Significant Companies of Ir-192 Table 21. Significant Companies of Se-75 Table 22. Significant Companies of Kr-85 Table 23. Significant Companies of Am-241 Table 24. Global Radioactive Source Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Radioactive Source Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Radioactive Source Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Radioactive Source Sales Value Share by Type (2021-2026) Table 28. Global Radioactive Source Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Table 30. Significant Companies of Industrial Table 31. Significant Companies of Agriculture Table 32. Significant Companies of Scientific Research Table 33. Significant Companies of Others Table 34. Global Radioactive Source Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Radioactive Source Sales Value by Application (2021-2026) & (US$ Million) Table 36. Global Radioactive Source Sales Value by Application (2027-2032) & (US$ Million) Table 37. Global Radioactive Source Sales Value Share by Application (2021-2026) Table 38. Global Radioactive Source Sales Value Share by Application (2027-2032) Table 39. Global Radioactive Source Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Radioactive Source Sales Value by Region (2021-2026) & (US$ Million) Table 41. Global Radioactive Source Sales Value Share by Region (2021-2026) Table 42. Global Radioactive Source Sales Value by Region (2027-2032) & (US$ Million) Table 43. Global Radioactive Source Sales Value Share by Region (2027-2032) Table 44. Global Radioactive Source Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Radioactive Source Sales Value by Country (2021-2026) & (US$ Million) Table 46. Global Radioactive Source Sales Value Market Share by Country (2021-2026) Table 47. Global Radioactive Source Sales Value by Country (2027-2032) & (US$ Million) Table 48. Global Radioactive Source Sales Value Market Share by Country (2027-2032) Table 49. NRG Company Information Table 50. NRG Business Overview Table 51. NRG Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. NRG Radioactive Source Product Portfolio Table 53. NRG Recent Development Table 54. Mayak Company Information Table 55. Mayak Business Overview Table 56. Mayak Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Mayak Radioactive Source Product Portfolio Table 58. Mayak Recent Development Table 59. NTP Radioisotopes Company Information Table 60. NTP Radioisotopes Business Overview Table 61. NTP Radioisotopes Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. NTP Radioisotopes Radioactive Source Product Portfolio Table 63. NTP Radioisotopes Recent Development Table 64. ANSTO Company Information Table 65. ANSTO Business Overview Table 66. ANSTO Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ANSTO Radioactive Source Product Portfolio Table 68. ANSTO Recent Development Table 69. Nordion Company Information Table 70. Nordion Business Overview Table 71. Nordion Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Nordion Radioactive Source Product Portfolio Table 73. Nordion Recent Development Table 74. IRE Company Information Table 75. IRE Business Overview Table 76. IRE Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. IRE Radioactive Source Product Portfolio Table 78. IRE Recent Development Table 79. Curium Pharma Company Information Table 80. Curium Pharma Business Overview Table 81. Curium Pharma Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Curium Pharma Radioactive Source Product Portfolio Table 83. Curium Pharma Recent Development Table 84. Eckert & Ziegler Strahlen Company Information Table 85. Eckert & Ziegler Strahlen Business Overview Table 86. Eckert & Ziegler Strahlen Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Eckert & Ziegler Strahlen Radioactive Source Product Portfolio Table 88. Eckert & Ziegler Strahlen Recent Development Table 89. China Isotope & Radiation Corporation (CIRC) Company Information Table 90. China Isotope & Radiation Corporation (CIRC) Business Overview Table 91. China Isotope & Radiation Corporation (CIRC) Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. China Isotope & Radiation Corporation (CIRC) Radioactive Source Product Portfolio Table 93. China Isotope & Radiation Corporation (CIRC) Recent Development Table 94. Polatom Company Information Table 95. Polatom Business Overview Table 96. Polatom Radioactive Source Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Polatom Radioactive Source Product Portfolio Table 98. Polatom Recent Development Table 99. Board of Radiation and Isotope Technology Company Information Table 100. Board of Radiation and Isotope Technology Business Overview Table 101. Board of Radiation and Isotope Technology Radioactive Source Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 102. Board of Radiation and Isotope Technology Radioactive Source Product Portfolio Table 103. Board of Radiation and Isotope Technology Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Radioactive Source Product Image Figure 2. Global Radioactive Source Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioactive Source Market Size (2021-2032) & (US$ Million) Figure 4. Global Radioactive Source Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mo-99 Image Figure 8. Co-60 Image Figure 9. Na-22 Image Figure 10. Co-57 Image Figure 11. Sr-90 Image Figure 12. I-131 Image Figure 13. Ir-192 Image Figure 14. Se-75 Image Figure 15. Kr-85 Image Figure 16. Am-241 Image Figure 17. Global Radioactive Source Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Radioactive Source Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Radioactive Source Sales Value Share by Type (2021-2032) Figure 20. Medical Image Figure 21. Industrial Image Figure 22. Agriculture Image Figure 23. Scientific Research Image Figure 24. Others Image Figure 25. Global Radioactive Source Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Radioactive Source Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Radioactive Source Sales Value Share by Application (2021-2032) Figure 28. Global Radioactive Source Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Radioactive Source Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Radioactive Source Sales Value (2021-2032) & (US$ Million) Figure 31. North America Radioactive Source Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Radioactive Source Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Radioactive Source Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Radioactive Source Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Radioactive Source Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Radioactive Source Sales Value (2021-2032) & (US$ Million) Figure 37. South America Radioactive Source Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Radioactive Source Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Radioactive Source Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Radioactive Source Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Radioactive Source Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Radioactive Source Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Years Considered Figure 125. Research Process Figure 126. Key Executives Interviewed

Scope & coverage.

Types
  • Mo-99
  • Co-60
  • Na-22
  • Co-57
  • Sr-90
  • I-131
  • Ir-192
  • Se-75
  • Kr-85
  • Am-241
Applications
  • Medical
  • Industrial
  • Agriculture
  • Scientific Research
  • Others
Companies covered
  • NRG
  • Mayak
  • NTP Radioisotopes
  • ANSTO
  • Nordion
  • IRE
  • Curium Pharma
  • Eckert & Ziegler Strahlen
  • China Isotope & Radiation Corporation (CIRC)
  • Polatom
  • Board of Radiation and Isotope Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radioactive Source Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radioactive Source Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Radioactive Source Market Dynamics
  1. 2.1 Radioactive Source Industry Trends
  2. 2.2 Radioactive Source Industry Drivers
  3. 2.3 Radioactive Source Industry Opportunities and Challenges
  4. 2.4 Radioactive Source Industry Restraints
3 Radioactive Source Market by Company
  1. 3.1 Global Radioactive Source Company Revenue Ranking in 2025
  2. 3.2 Global Radioactive Source Revenue by Company (2021-2026)
  3. 3.3 Global Radioactive Source Company Ranking (2024-2026)
  4. 3.4 Global Radioactive Source Company Manufacturing Base and Headquarters
  5. 3.5 Global Radioactive Source Company Product Type and Application
  6. 3.6 Global Radioactive Source Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Radioactive Source Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Radioactive Source Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Radioactive Source Market by Type
  1. 4.1 Radioactive Source Type Introduction
  2. 4.1.1 Mo-99
  3. 4.1.2 Co-60
  4. 4.1.3 Na-22
  5. 4.1.4 Co-57
  6. 4.1.5 Sr-90
  7. 4.1.6 I-131
  8. 4.1.7 Ir-192
  9. 4.1.8 Se-75
  10. 4.1.9 Kr-85
  11. 4.1.10 Am-241
  12. 4.2 Global Radioactive Source Sales Value by Type
  13. 4.2.1 Global Radioactive Source Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.2.2 Global Radioactive Source Sales Value by Type (2021-2032)
  15. 4.2.3 Global Radioactive Source Sales Value Share by Type (2021-2032)
5 Radioactive Source Market by Application
  1. 5.1 Radioactive Source Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Industrial
  4. 5.1.3 Agriculture
  5. 5.1.4 Scientific Research
  6. 5.1.5 Others
  7. 5.2 Global Radioactive Source Sales Value by Application
  8. 5.2.1 Global Radioactive Source Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Radioactive Source Sales Value by Application (2021-2032)
  10. 5.2.3 Global Radioactive Source Sales Value Share by Application (2021-2032)
6 Radioactive Source Regional Value Analysis
  1. 6.1 Global Radioactive Source Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radioactive Source Sales Value by Region (2021-2032)
  3. 6.2.1 Global Radioactive Source Sales Value by Region: 2021-2026
  4. 6.2.2 Global Radioactive Source Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radioactive Source Sales Value (2021-2032)
  7. 6.3.2 North America Radioactive Source Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Radioactive Source Sales Value (2021-2032)
  10. 6.4.2 Europe Radioactive Source Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Radioactive Source Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Radioactive Source Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Radioactive Source Sales Value (2021-2032)
  16. 6.6.2 South America Radioactive Source Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Radioactive Source Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Radioactive Source Sales Value Share by Country, 2025 VS 2032
7 Radioactive Source Country-level Value Analysis
  1. 7.1 Global Radioactive Source Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radioactive Source Sales Value by Country (2021-2032)
  3. 7.2.1 Global Radioactive Source Sales Value by Country (2021-2026)
  4. 7.2.2 Global Radioactive Source Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Radioactive Source Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Radioactive Source Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Radioactive Source Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Radioactive Source Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Radioactive Source Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Radioactive Source Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Radioactive Source Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Radioactive Source Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Radioactive Source Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Radioactive Source Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Radioactive Source Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Radioactive Source Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Radioactive Source Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Radioactive Source Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Radioactive Source Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Radioactive Source Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Radioactive Source Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Radioactive Source Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Radioactive Source Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Radioactive Source Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Radioactive Source Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Radioactive Source Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Radioactive Source Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Radioactive Source Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Radioactive Source Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Radioactive Source Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Radioactive Source Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Radioactive Source Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Radioactive Source Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Radioactive Source Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Radioactive Source Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Radioactive Source Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Radioactive Source Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Radioactive Source Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Radioactive Source Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Radioactive Source Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Radioactive Source Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Radioactive Source Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Radioactive Source Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Radioactive Source Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Radioactive Source Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Radioactive Source Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Radioactive Source Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Radioactive Source Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Radioactive Source Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Radioactive Source Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Radioactive Source Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Radioactive Source Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Radioactive Source Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Radioactive Source Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Radioactive Source Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Radioactive Source Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Radioactive Source Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Radioactive Source Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Radioactive Source Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Radioactive Source Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Radioactive Source Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Radioactive Source Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Radioactive Source Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Radioactive Source Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Radioactive Source Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Radioactive Source Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Radioactive Source Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Radioactive Source Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Radioactive Source Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Radioactive Source Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Radioactive Source Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Radioactive Source Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Radioactive Source Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Radioactive Source Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Radioactive Source Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Radioactive Source Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Radioactive Source Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Radioactive Source Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Radioactive Source Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Radioactive Source Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Radioactive Source Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Radioactive Source Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Radioactive Source Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Radioactive Source Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Radioactive Source Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Radioactive Source Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Radioactive Source Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Radioactive Source Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NRG
  2. 8.1.1 NRG Company Information
  3. 8.1.2 NRG Business Overview
  4. 8.1.3 NRG Radioactive Source Revenue and Gross Margin (2021-2026)
  5. 8.1.4 NRG Radioactive Source Product Portfolio
  6. 8.1.5 NRG Recent Developments
  7. 8.2 Mayak
  8. 8.2.1 Mayak Company Information
  9. 8.2.2 Mayak Business Overview
  10. 8.2.3 Mayak Radioactive Source Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mayak Radioactive Source Product Portfolio
  12. 8.2.5 Mayak Recent Developments
  13. 8.3 NTP Radioisotopes
  14. 8.3.1 NTP Radioisotopes Company Information
  15. 8.3.2 NTP Radioisotopes Business Overview
  16. 8.3.3 NTP Radioisotopes Radioactive Source Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NTP Radioisotopes Radioactive Source Product Portfolio
  18. 8.3.5 NTP Radioisotopes Recent Developments
  19. 8.4 ANSTO
  20. 8.4.1 ANSTO Company Information
  21. 8.4.2 ANSTO Business Overview
  22. 8.4.3 ANSTO Radioactive Source Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ANSTO Radioactive Source Product Portfolio
  24. 8.4.5 ANSTO Recent Developments
  25. 8.5 Nordion
  26. 8.5.1 Nordion Company Information
  27. 8.5.2 Nordion Business Overview
  28. 8.5.3 Nordion Radioactive Source Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nordion Radioactive Source Product Portfolio
  30. 8.5.5 Nordion Recent Developments
  31. 8.6 IRE
  32. 8.6.1 IRE Company Information
  33. 8.6.2 IRE Business Overview
  34. 8.6.3 IRE Radioactive Source Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IRE Radioactive Source Product Portfolio
  36. 8.6.5 IRE Recent Developments
  37. 8.7 Curium Pharma
  38. 8.7.1 Curium Pharma Company Information
  39. 8.7.2 Curium Pharma Business Overview
  40. 8.7.3 Curium Pharma Radioactive Source Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Curium Pharma Radioactive Source Product Portfolio
  42. 8.7.5 Curium Pharma Recent Developments
  43. 8.8 Eckert & Ziegler Strahlen
  44. 8.8.1 Eckert & Ziegler Strahlen Company Information
  45. 8.8.2 Eckert & Ziegler Strahlen Business Overview
  46. 8.8.3 Eckert & Ziegler Strahlen Radioactive Source Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eckert & Ziegler Strahlen Radioactive Source Product Portfolio
  48. 8.8.5 Eckert & Ziegler Strahlen Recent Developments
  49. 8.9 China Isotope & Radiation Corporation (CIRC)
  50. 8.9.1 China Isotope & Radiation Corporation (CIRC) Company Information
  51. 8.9.2 China Isotope & Radiation Corporation (CIRC) Business Overview
  52. 8.9.3 China Isotope & Radiation Corporation (CIRC) Radioactive Source Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China Isotope & Radiation Corporation (CIRC) Radioactive Source Product Portfolio
  54. 8.9.5 China Isotope & Radiation Corporation (CIRC) Recent Developments
  55. 8.10 Polatom
  56. 8.10.1 Polatom Company Information
  57. 8.10.2 Polatom Business Overview
  58. 8.10.3 Polatom Radioactive Source Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Polatom Radioactive Source Product Portfolio
  60. 8.10.5 Polatom Recent Developments
  61. 8.11 Board of Radiation and Isotope Technology
  62. 8.11.1 Board of Radiation and Isotope Technology Company Information
  63. 8.11.2 Board of Radiation and Isotope Technology Business Overview
  64. 8.11.3 Board of Radiation and Isotope Technology Radioactive Source Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Board of Radiation and Isotope Technology Radioactive Source Product Portfolio
  66. 8.11.5 Board of Radiation and Isotope Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst